Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
9.65M
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
21.5M
-
Shares change
-
-148K
-
Total reported value, excl. options
-
$733M
-
Value change
-
+$29.3M
-
Number of buys
-
49
-
Number of sells
-
-31
-
Price
-
$34.25
Significant Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q4 2020
88 filings reported holding ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value as of Q4 2020.
Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.5M shares
.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.11M shares), RTW INVESTMENTS, LP (2.69M shares), VIKING GLOBAL INVESTORS LP (2.12M shares), VR Adviser, LLC (1.69M shares), CITADEL ADVISORS LLC (1.16M shares), Avidity Partners Management LP (1.04M shares), JANUS HENDERSON GROUP PLC (956K shares), Logos Global Management LP (948K shares), BlackRock Inc. (871K shares), and Rock Springs Capital Management LP (861K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.